Esma R Isenovic Selected Research

Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)

3/2018	Regulation of hepatic Na+/K+-ATPase in obese female and male rats: involvement of ERK1/2, AMPK, and Rho/ROCK.
1/2017	Regulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseases.
9/2013	Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases.
4/2008	Hypothetical mechanism of sodium pump regulation by estradiol under primary hypertension.
1/2007	Regulation of the inducible nitric oxide synthase and sodium pump in type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Esma R Isenovic Research Topics

Disease

16	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2010
16	Obesity 01/2021 - 03/2013
11	Inflammation (Inflammations) 01/2022 - 06/2010
7	Atherosclerosis 01/2022 - 01/2013
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 11/2011
7	Insulin Resistance 01/2017 - 01/2007
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2013
4	Hypothyroidism 01/2022 - 01/2016
4	Stroke (Strokes) 01/2020 - 10/2011
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 01/2007
4	Heart Failure 01/2017 - 04/2008
3	Body Weight (Weight, Body) 01/2022 - 10/2011
3	Brain Ischemia (Cerebral Ischemia) 01/2020 - 09/2014
3	Hypertension (High Blood Pressure) 01/2017 - 04/2008
2	Thyroid Diseases (Thyroid Disease) 01/2021 - 10/2019
2	Vascular Diseases (Vascular Disease) 01/2021 - 01/2010
2	Neoplasms (Cancer) 01/2021 - 10/2017
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2020 - 10/2011
2	Hypertrophy 01/2019 - 01/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2018 - 08/2010
2	Liver Diseases (Liver Disease) 09/2017 - 04/2010
2	Metabolic Diseases (Metabolic Disease) 01/2017 - 01/2017
2	Diabetes Mellitus 02/2015 - 01/2015
2	Acute Coronary Syndrome 01/2015 - 08/2010
1	Vascular Remodeling 01/2022
1	Rupture 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Osteoporosis 01/2021
1	Infertility (Sterility) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Atrial Fibrillation 01/2021
1	Ulcer 04/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Peptic Esophagitis (Reflux Esophagitis) 01/2020
1	Brain Hypoxia (Cerebral Hypoxia) 01/2020
1	Bile Reflux 01/2020
1	Barrett Esophagus (Barrett's Esophagus) 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Vitamin D Deficiency 01/2018
1	Myocardial Infarction 01/2018

Drug/Important Bio-Agent (IBA)

9	Insulin (Novolin)FDA Link 01/2022 - 01/2010
7	LipidsIBA 10/2019 - 10/2011
7	Estradiol (Delestrogen)FDA LinkGeneric 11/2018 - 04/2008
6	Vitamin D FDA LinkGeneric 01/2021 - 08/2015
6	Biomarkers (Surrogate Marker)IBA 04/2020 - 01/2013
5	C-Reactive ProteinIBA 01/2022 - 01/2011
5	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 03/2018 - 01/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2010
4	AntioxidantsIBA 01/2021 - 09/2010
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019 - 01/2007
4	Adenosine Triphosphatases (ATPase)IBA 03/2018 - 09/2013
4	Proteins (Proteins, Gene)FDA Link 11/2015 - 06/2010
4	oxidized low density lipoproteinIBA 01/2015 - 01/2013
3	Oxygen (Dioxygen)IBA 01/2022 - 01/2019
3	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2021 - 01/2015
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2020 - 01/2017
3	EnzymesIBA 01/2020 - 09/2010
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 03/2013
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019 - 01/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2014 - 06/2010
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2011
2	InterferonsIBA 01/2022 - 01/2010
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2021 - 01/2016
2	Messenger RNA (mRNA)IBA 10/2017 - 06/2010
2	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 01/2007
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2016 - 01/2015
2	GhrelinIBA 02/2015 - 01/2013
2	Hormones (Hormone)IBA 01/2015 - 09/2014
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2010 - 01/2007
1	CollagenIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Vasodilator Agents (Vasodilators)IBA 01/2022
1	CytokinesIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	LeptinIBA 01/2021
1	Thyroid HormonesIBA 01/2021
1	Proton Pump InhibitorsIBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020
1	HomoarginineIBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	AcidsIBA 01/2020
1	Amino Acids FDA Link 01/2020
1	Taurine FDA Link 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 05/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Proprotein Convertase 9IBA 01/2018
1	MicronutrientsIBA 01/2018
1	hydroxide ionIBA 01/2018

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2010
2	Carotid Endarterectomy 01/2020 - 10/2011
1	Thyroidectomy 01/2021
1	Radiofrequency Ablation 01/2020
1	Hyperbaric Oxygenation 01/2019
1	Drug Therapy (Chemotherapy) 01/2018